These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 2900488
1. [In vitro activity of roxithromycin against hospital bacteria and the concordance curve]. Soussy CJ, Chanal M, Kitzis MD, Duval J, Cluzel R, Acar JF. Pathol Biol (Paris); 1988 May; 36(5):420-4. PubMed ID: 2900488 [Abstract] [Full Text] [Related]
2. [In vitro antibacterial activity of clarithromycin, a new macrolide antibiotic, and regression curve]. Soussy CJ, Le Van Thoi J, Cluzel M, Derlot E, Kitzis MD. Pathol Biol (Paris); 1990 May; 38(5):401-6. PubMed ID: 2142274 [Abstract] [Full Text] [Related]
3. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study]. Soussy CJ, Deforges L, Le Van Thoi J, Chanal M, Sirot D, Acar JF, Kitzis MD, Thabaut A, Meyran M, Dabernat H. Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):469-72. PubMed ID: 2868442 [Abstract] [Full Text] [Related]
4. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria]. Soussy CJ, Otterbein G, Le Van Thoi J, Thabaut A, Meyran M, Courtieu AL, Reynaud A, Dabernat H, Lareng MB, Chanal M. Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142 [Abstract] [Full Text] [Related]
5. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics. Drabu YJ, Mehtar S, Blakemore PH. Drugs Exp Clin Res; 1987 Jun; 13(4):201-3. PubMed ID: 3622250 [Abstract] [Full Text] [Related]
6. [In vitro antibacterial activity of apalcillin on aerobic bacteria and the regression curve]. Soussy CJ, Duval J, Chanal M, Sirot D, Bergogne-Bérézin E, Joly-Guillou ML, Malbruny B, Morel C. Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):660-4. PubMed ID: 3054743 [Abstract] [Full Text] [Related]
7. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin. King A, Phillips I. Drugs Exp Clin Res; 1987 Jun; 13(9):563-6. PubMed ID: 3428135 [Abstract] [Full Text] [Related]
8. [In vitro antibacterial activity of a new macrolide, miokamycin. Results of a multicenter study]. Soussy CJ, Thabaut A, Bismuth R, Morel C, Berthelot G, Chanal M, Derlot E. Pathol Biol (Paris); 1989 May; 37(5):358-63. PubMed ID: 2674868 [Abstract] [Full Text] [Related]
9. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes]. Dubreuil L, Devos J, Romond C, Bryskier A. Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717 [Abstract] [Full Text] [Related]
10. [In vitro activity of ceftizoxime on hospital bacteria. Results of a multicenter study]. Soussy CJ, Deforges L, Le Van Thoi J, Thabaut A, Meyran M, Chanal M, Cluzel M, Brun Y, Coulet M, Fleurette J. Pathol Biol (Paris); 1984 May; 32(5):326-30. PubMed ID: 6330645 [Abstract] [Full Text] [Related]
11. [In vitro antibacterial activity of a new fluoroquinolone, temafloxacin, against hospital isolates. Results of a multicenter study]. Soussy CJ, Morel C, Kitzis MD, Meyran M, Brun Y, Joly-Guillou ML, Dabernat H, Chanal M, Courtieu AL, Derlot E. Pathol Biol (Paris); 1991 May; 39(5):403-9. PubMed ID: 1881670 [Abstract] [Full Text] [Related]
12. [Multicenter study of ofloxacin activity on bacteria isolated from a hospital environment]. Soussy CJ, Le Van Thoi J, Duval J, Morel C, Malbruny B, Acar JF, Kitzis MD, Mounier M, Denis F, Courvalin P. Pathol Biol (Paris); 1986 May; 34(5):390-8. PubMed ID: 3534711 [Abstract] [Full Text] [Related]
13. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates. Dibb WL, Ragnhildstveit E. NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004 [Abstract] [Full Text] [Related]
14. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin]. Soussy CJ, Leclercq R, Duval J. Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331 [Abstract] [Full Text] [Related]
15. [In vitro activity of roxithromycin compared to 5 other macrolides against staphylococci]. Brun Y, Coulet M, Forey F, Fleurette J. Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):613-8. PubMed ID: 3054736 [Abstract] [Full Text] [Related]
17. [Comparative in vitro bacteriostatic and bactericidal effect of 5 macrolides: roxithromycin, erythromycin, oleandomycin, josamycin and spiramycin against 284 hospital bacterial strains]. Le Noc P, Croize J, Bryskier A, Le Noc D, Robert J. Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):553-9. PubMed ID: 2797879 [Abstract] [Full Text] [Related]
18. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria]. Soussy CJ, Otterbein G, Le Van Thoi J, Duval J, Chanal M, Cluzel M, Sirot D. Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743 [Abstract] [Full Text] [Related]
19. [Multicenter study of the antibacterial activity of a new cephalosporin: CM 40874]. Duval J, Soussy CJ, Deforges L, Brun Y, Coulet M, Forey F, Thabaut A, Meyran M, Acar JF, Kitzis MD. Pathol Biol (Paris); 1984 May; 32(5):331-4. PubMed ID: 6547524 [Abstract] [Full Text] [Related]
20. Josamycin: interpretation of inhibition zones with the Bauer-Kirby agar disk diffusion test as compared with erythromycin. Karthein J, Spohr M, Traub WH. Chemotherapy; 1986 May; 32(4):336-43. PubMed ID: 3731919 [Abstract] [Full Text] [Related] Page: [Next] [New Search]